These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24682467)

  • 1. Epirubicin upregulates UDP glucuronosyltransferase 2B7 expression in liver cancer cells via the p53 pathway.
    Hu DG; Rogers A; Mackenzie PI
    Mol Pharmacol; 2014 Jun; 85(6):887-97. PubMed ID: 24682467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of human UDP-Glucuronosyltransferase 2B7 gene expression by cytotoxic anticancer drugs in liver cancer HepG2 cells.
    Hu DG; Mackenzie PI; Lu L; Meech R; McKinnon RA
    Drug Metab Dispos; 2015 May; 43(5):660-8. PubMed ID: 25713207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octamer transcription factor-1 enhances hepatic nuclear factor-1alpha-mediated activation of the human UDP glucuronosyltransferase 2B7 promoter.
    Ishii Y; Hansen AJ; Mackenzie PI
    Mol Pharmacol; 2000 May; 57(5):940-7. PubMed ID: 10779377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7.
    Innocenti F; Iyer L; Ramírez J; Green MD; Ratain MJ
    Drug Metab Dispos; 2001 May; 29(5):686-92. PubMed ID: 11302935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms in the 5'-flanking region of human UDP-glucuronosyltransferase 2B7 affect the Nrf2-dependent transcriptional regulation.
    Nakamura A; Nakajima M; Higashi E; Yamanaka H; Yokoi T
    Pharmacogenet Genomics; 2008 Aug; 18(8):709-20. PubMed ID: 18622263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.
    Nasr M; Nafee N; Saad H; Kazem A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):216-25. PubMed ID: 24813390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of UGT2B7 is driven by two mutually exclusive promoters and alternative splicing in human tissues: changes from prenatal life to adulthood and in kidney cancer.
    Ménard V; Lévesque E; Chen S; Eap O; Joy MS; Ekström L; Rane A; Guillemette C
    Pharmacogenet Genomics; 2013 Dec; 23(12):684-96. PubMed ID: 24128937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epirubicin glucuronidation and UGT2B7 developmental expression.
    Zaya MJ; Hines RN; Stevens JC
    Drug Metab Dispos; 2006 Dec; 34(12):2097-101. PubMed ID: 16985101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HSF1 upregulates ATG4B expression and enhances epirubicin-induced protective autophagy in hepatocellular carcinoma cells.
    Zhang N; Wu Y; Lyu X; Li B; Yan X; Xiong H; Li X; Huang G; Zeng Y; Zhang Y; Lian J; Ni Z; He F
    Cancer Lett; 2017 Nov; 409():81-90. PubMed ID: 28889000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistance.
    Millour J; de Olano N; Horimoto Y; Monteiro LJ; Langer JK; Aligue R; Hajji N; Lam EW
    Mol Cancer Ther; 2011 Jun; 10(6):1046-58. PubMed ID: 21518729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus X protein inhibits p53-mediated upregulation of mitofusin-2 in hepatocellular carcinoma cells.
    Wang W; Zhou D; Wei J; Wu Z; Cheng X; Sun Q; Xie H; Zhou L; Zheng S
    Biochem Biophys Res Commun; 2012 May; 421(2):355-60. PubMed ID: 22510407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithocholic acid decreases expression of UGT2B7 in Caco-2 cells: a potential role for a negative farnesoid X receptor response element.
    Lu Y; Heydel JM; Li X; Bratton S; Lindblom T; Radominska-Pandya A
    Drug Metab Dispos; 2005 Jul; 33(7):937-46. PubMed ID: 15821044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ulinastatin reduces the resistance of liver cancer cells to epirubicin by inhibiting autophagy.
    Song B; Bian Q; Shao CH; Li G; Liu AA; Jing W; Liu R; Zhang YJ; Zhou YQ; Hu XG; Jin G
    PLoS One; 2015; 10(3):e0120694. PubMed ID: 25815885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of UGT2B Expression and Activity by miR-216b-5p in Liver Cancer Cell Lines.
    Dluzen DF; Sutliff AK; Chen G; Watson CJ; Ishmael FT; Lazarus P
    J Pharmacol Exp Ther; 2016 Oct; 359(1):182-93. PubMed ID: 27474751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients.
    Holthe M; Rakvåg TN; Klepstad P; Idle JR; Kaasa S; Krokan HE; Skorpen F
    Pharmacogenomics J; 2003; 3(1):17-26. PubMed ID: 12629580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3'-azido-3'-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7).
    Barbier O; Turgeon D; Girard C; Green MD; Tephly TR; Hum DW; Bélanger A
    Drug Metab Dispos; 2000 May; 28(5):497-502. PubMed ID: 10772627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The caudal-related homeodomain protein Cdx2 and hepatocyte nuclear factor 1alpha cooperatively regulate the UDP-glucuronosyltransferase 2B7 gene promoter.
    Gregory PA; Gardner-Stephen DA; Rogers A; Michael MZ; Mackenzie PI
    Pharmacogenet Genomics; 2006 Jul; 16(7):527-36. PubMed ID: 16788384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the UGT2B7 enzyme activity by C-terminally truncated proteins derived from alternative splicing.
    Ménard V; Collin P; Margaillan G; Guillemette C
    Drug Metab Dispos; 2013 Dec; 41(12):2197-205. PubMed ID: 24088326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender Differences in the Hepatotoxicity and Toxicokinetics of Emodin: The Potential Mechanisms Mediated by UGT2B7 and MRP2.
    Wu L; Han W; Chen Y; Zhang T; Liu J; Zhong S; Liu H; Han C; Zhang Z; Liu S; Tang L
    Mol Pharm; 2018 Sep; 15(9):3931-3945. PubMed ID: 30011215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. siRNA-mediated type 1 insulin-like growth factor receptor silencing induces chemosensitization of a human liver cancer cell line with mutant P53.
    Niu J; Xu Z; Li XN; Han Z
    Cell Biol Int; 2007 Feb; 31(2):156-64. PubMed ID: 17097318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.